Skip to content

Clinical trials

Prostatic Neoplasms trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Malaysia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20133
20152
20161
20171
20181
20192
20201
20233
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting6
Recruiting4
Unknown status2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
AstraZeneca2
Merck Sharp & Dohme LLC2
University of Malaya2
Aragon Pharmaceuticals, Inc.1
Astellas Pharma Global Development, Inc.1
Astellas Pharma Singapore Pte. Ltd.1
CytoMed Therapeutics Pte Ltd1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms20
Acromegaly1
Agnosia1
Colorectal Neoplasms1
Dumping Syndrome1
Genital Diseases, Male1
Genital Neoplasms, Male1
Head and Neck Neoplasms1
Melanoma1
Nasopharyngeal Carcinoma1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.